| Nirogacestat, a γ-secretase inhibitor for desmoid tumors M Gounder, R Ratan, T Alcindor, P Schöffski, WT Van Der Graaf, BA Wilky, ... New England Journal of Medicine 388 (10), 898-912, 2023 | 168 | 2023 |
| Cell-free DNA from ascites and pleural effusions: molecular insights into genomic aberrations and disease biology H Husain, D Nykin, N Bui, D Quan, G Gomez, B Woodward, ... Molecular cancer therapeutics 16 (5), 948-955, 2017 | 93 | 2017 |
| Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers M Ando, Y Saito, G Xu, NQ Bui, K Medetgul-Ernar, M Pu, K Fisch, S Ren, ... Nature communications 10 (1), 2188, 2019 | 89 | 2019 |
| A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis NQ Bui, J Przybyl, SE Trabucco, G Frampton, T Hastie, M van de Rijn, ... Clinical Sarcoma Research 9, 1-11, 2019 | 71 | 2019 |
| Disruption of NSD1 in Head and Neck Cancer Promotes Favorable Chemotherapeutic Responses Linked to Hypomethylation N Bui, JK Huang, A Bojorquez-Gomez, K Licon, KS Sanchez, SN Tang, ... Molecular cancer therapeutics 17 (7), 1585-1594, 2018 | 55 | 2018 |
| Reviewing the role of healthy volunteer studies in drug development JJ Karakunnel, N Bui, L Palaniappan, KT Schmidt, KW Mahaffey, ... Journal of translational medicine 16, 1-15, 2018 | 53 | 2018 |
| Next-generation sequencing of tissue and circulating tumor DNA: the UC San Diego Moores Center for personalized cancer therapy experience with breast malignancies R Shatsky, BA Parker, NQ Bui, T Helsten, RB Schwab, SG Boles, ... Molecular Cancer Therapeutics 18 (5), 1001-1011, 2019 | 48 | 2019 |
| Dorsal aesthetic lines in rhinoplasty: a quantitative outcome-based assessment of the component dorsal reduction technique A Mojallal, D Ouyang, M Saint-Cyr, N Bui, SA Brown, RJ Rohrich Plastic and reconstructive surgery 128 (1), 280-288, 2011 | 45 | 2011 |
| Strategies to overcome bypass mechanisms mediating clinical resistance to EGFR tyrosine kinase inhibition in lung cancer H Husain, M Scur, A Murtuza, N Bui, B Woodward, R Kurzrock Molecular cancer therapeutics 16 (2), 265-272, 2017 | 42 | 2017 |
| Targeted long-read sequencing reveals clonally expanded HBV-associated chromosomal translocations in patients with chronic hepatitis B N van Buuren, R Ramirez, C Soulette, V Suri, D Han, L May, S Turner, ... JHEP Reports 4 (4), 100449, 2022 | 39 | 2022 |
| Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection N van Buuren, R Ramirez, S Turner, D Chen, V Suri, A Aggarwal, C Moon, ... JHEP Reports 4 (1), 100388, 2022 | 37 | 2022 |
| Current management and recent progress in desmoid tumors MY Zhou, NQ Bui, GW Charville, P Ghanouni, KN Ganjoo Cancer Treatment and Research Communications 31, 100562, 2022 | 26 | 2022 |
| Contemporary management of metastatic soft tissue sarcoma NQ Bui, DS Wang, SM Hiniker Current Problems in Cancer 43 (4), 289-299, 2019 | 26 | 2019 |
| Novel treatment strategies for brain metastases in non-small-cell lung cancer N Bui, B Woodward, A Johnson, H Husain Current treatment options in oncology 17, 1-17, 2016 | 24 | 2016 |
| Cutaneous angiosarcoma of the head and neck—A retrospective analysis of 47 patients N Ramakrishnan, R Mokhtari, GW Charville, N Bui, K Ganjoo Cancers 14 (15), 3841, 2022 | 21 | 2022 |
| Phase II study of olaparib and temozolomide for advanced uterine leiomyosarcoma (NCI Protocol 10250) M Ingham, JB Allred, L Chen, B Das, B Kochupurakkal, K Gano, S George, ... Journal of Clinical Oncology 41 (25), 4154-4163, 2023 | 20 | 2023 |
| A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma N Bui, N Kamat, V Ravi, S Chawla, M Lohman, KN Ganjoo Rare tumors 10, 2036361318771771, 2018 | 19 | 2018 |
| Evaluation of absolute lymphocyte count at diagnosis and mortality among patients with localized bone or soft tissue sarcoma R Brewster, N Purington, S Henry, D Wood, K Ganjoo, N Bui JAMA network open 4 (3), e210845-e210845, 2021 | 17 | 2021 |
| Evolution of early phase clinical trials in oncology NQ Bui, S Kummar Journal of Molecular Medicine 96 (1), 31-38, 2018 | 17 | 2018 |
| Safety and feasibility of cryoablation during immunotherapy in patients with metastatic soft tissue sarcoma A Doshi, M Zhou, N Bui, DS Wang, K Ganjoo, GL Hwang Journal of Vascular and Interventional Radiology 32 (12), 1688-1694, 2021 | 16 | 2021 |
